Sells general insurance products across motor, health, fire, and other commercial lines to Indian retail and corporate policyholders. Motor is the largest single segment, holding 10.5% market share with 14% growth in Q1 FY27. Health insurance is split between retail and group, with retail health surging 69.5% in Q1 FY27 and lifting market share from 3.5% to 4.5%. Commercial lines, especially fire, de-grew 13.8% in Q1 FY27 as the company pulled back from pricing-aggressive accounts. Gross Direct Premium Income for Q1 FY27 was Rs 83.18 billion, growing 7.5% versus industry growth of 10.9%. Underwriting profitability is captured in the combined ratio, which rose to 107.2% in Q1 FY27 — including Rs 1.65 billion of motor third-party provisioning tied to a Supreme Court ruling on homemaker compensation and Rs 0.63 billion in two large fire losses; the underlying CoR was 102.3%. The 10-year average CoR of 102.9% sits below the industry's 115.3%. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Motor insurance, Health insurance, Commercial lines (Fire and others). General insurance underwriter with motor, health and fire exposure; pricing- and claims-cycle driven, regulated by solvency norms
| ₹ crore · consolidated | FY21 | FY22 | FY23 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| EBITDA (ex other income) | — | — | — | — | — |
| margin % | — | — | — | — | — |
| Owners' profit | 1,473 | 1,271 | 1,729 | 2,508 | 2,772 |
| EPS, as reported (₹) | — | — | — | — | — |
| ROE % · ROCE % | — · — | — · — | — · — | — · — | — · — |
| Debt / equity (x) | — | — | — | — | — |
| Cash from operations | 1,774 | 809 | 2,290 | 1,147 | 2,622 |
| Capex | (79) | (76) | (121) | (231) | (243) |
| ₹ crore | Q2 FY24 | Q3 FY24 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Profit before tax | — | — | — | — | — | — | — | — |
| Net profit | 577 | 431 | 510 | 747 | 820 | 659 | 547 | 403 |
| EPS (₹) | — | — | — | — | — | — | — | — |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| ICICI LOMBARD GIC LIMITED ◆ | — | — | — | — | — | — | — | — |
| THE NEW INDIA ASSU CO LTD | — | — | — | — | — | — | — | — |
| STAR HEALTH & AL INS CO L | — | — | — | — | — | — | — | — |
| GO DIGIT GENERAL INS LTD | — | — | — | — | — | — | — | — |
| GENERAL INS CORP OF INDIA | — |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 11 Sept 2026 · ICICI Lombard publishes notice for lost share certificates | compliance | minimal | — | — |
| 8 Sept 2026 · IRDAI imposes Rs 1 crore penalty on ICICI Lombard for outsourcing lapses | general | medium | — | — |
| 2 Sept 2026 · ICICI Lombard allots 4,212 equity shares under employee stock schemes | capital market events | low | — | — |
| 2 Sept 2026 · ICICI Lombard loses GST appeals; aggregate demand rises to about Rs 3.30 crore | general | medium | — | — |
| 24 Aug 2026 · ICICI Lombard allots 71,297 shares under ESOP schemes | capital market events | low | — | — |
| 20 Aug 2026 · ICICI Lombard announces investor meet schedule for September 2026 | board shareholder meetings | low | — | — |
| 12 Aug 2026 · ICICI Lombard shifts Aug 28 investor meet to virtual mode | board shareholder meetings | low | — | — |
| 11 Aug 2026 · ICICI Lombard to attend Motilal Oswal investor conference on Aug 18 | board shareholder meetings | low | — | — |
| 8 Aug 2026 · ICICI Lombard flags erroneous 96.96 cr tax refund adjustment | regulatory legal | medium | — | — |
| 7 Aug 2026 · ICICI Lombard: Transfer of unclaimed shares and dividend to IEPF | compliance | low | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions |
| — |
| — |
| — |
| — |
| — |
| — |
| — |
| NIVA BUPA HEALTH INS CO L | — | — | — | — | — | — | — | — |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| Profit growth | (46.0) | 21.9 | 11 of 12 | 9% |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
